11 Recruiting Large B-cell Lymphoma Phase 2 Clinical Trials
Active phase 2 studies for large b-cell lymphoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Large B-cell Lymphoma studiesPhase 2 Studies for Large B-cell Lymphoma
🟡 Not Yet Recruiting Phase2
Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2
CAR-T Followed by Bispecific Antibodies
📍 University of Nebraska Medical Center — Omaha, Nebraska
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Study to Evaluate Zanubrutinib and Tislelizumab in Progressive Lymphoma Post CAR-T
📍 University Health Network (UHN) — Toronto, Ontario
View Study & Checklist ➔ 🟢 Recruiting Phase2
Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2
Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma
📍 University of Miami — Miami, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2
Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2
Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2
Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2
Emapalumab Prevention of CAR-T Cell Associated Toxicities
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔